Journal profile · ONCOLOGY
World Journal of Oncology
ISSN 1920-4531 · eISSN 1920-454X · Elmer Press Inc
World Journal of Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; median 58 days to acceptance (100 articles, last 24 months); 74 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
World Journal of Oncology is published by Elmer Press Inc and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Lung Cancer Diagnosis and Treatment and Metastasis and carcinoma case studies, together about 21.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
World Journal of Oncology publishes original contributions describing basic research and clinical investigation of cancer, on the cellular, molecular, prevention, diagnosis, therapy, translational oncology, and prognosis aspects. The submissions can be basic research or clinical investigation oriented. This journal welcomes those submissions focused on the clinical trials of new treatment modalities for cancer, and those submissions focused on molecular or cellular research of the oncology pathogenesis. Case reports submitted for consideration of publication should explore either a novel genomic event/description or a new safety signal from an oncolytic agent. The areas of interested manuscripts are these disciplines: tumor immunology and immunotherapy; cancer molecular pharmacology and chemotherapy; drug sensitivity and resistance; cancer epidemiology; clinical trials; cancer pathology; radiobiology and radiation oncology; solid tumor oncology; hematological malignancies; surgical oncology; pediatric oncology; molecular oncology and cancer genes; gene therapy; cancer endocrinology; cancer metastasis; prevention and diagnosis of cancer; other cancer related subjects. The types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology9.4%
- Lung Cancer Diagnosis and TreatmentMedicine6.1%
- Metastasis and carcinoma case studiesMedicine6.1%
- Cancer Immunotherapy and BiomarkersMedicine5.8%
- Breast Lesions and CarcinomasMedicine5.8%
- Head and Neck Cancer StudiesMedicine5.2%
- Lung Cancer Research StudiesMedicine4.6%
- Lymphoma Diagnosis and TreatmentMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q3 | 243/428 | 43rd |
| Cancer Research | Q3 | 168/233 | 28th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.5LetPub ·
- SJR 2026-06
- 0.74LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 33OpenAlex ·
- i10-index
- 188OpenAlex ·
- 2-year mean citedness
- 2.87OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 61LetPub ·
Articles by year OpenAlex count · 792 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 50 | 1,458 |
| 2025 | 74 | 74 | 2,056 |
| 2024 | 88 | 88 | 1,927 |
| 2023 | 68 | 68 | 1,907 |
| 2022 | 50 | 50 | 1,791 |
| 2021 | 34 | 34 | 1,575 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
58 daysMedian, submission to acceptance · P25–P75 44 days – 73 days
- Acceptance to online
- median 27 days (100 articles)
- Submission to online
- median 89 days
- Sample
- 100 articles with submission and acceptance dates (133 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7
- book reviewThe types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.Length not stated
- case reportThe types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.Length not stated
- editorialThe types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.Length not stated
- letter to the editorThe types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.Length not stated
- original articlesThe types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.Length not stated
- reviewThe types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.Length not stated
- short communicationThe types of manuscripts accepted are original articles, review, editorial, short communication, case report, letter to the editor, book review.Length not stated
Policy excerpts from the journal's websitePublication ethics, Open access
- Publication ethics
Follows ICMJE recommendations, COPE guidelines, and Principles of Transparency and Best Practice in Scholarly Publishing. Model summary
This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals, the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.
Source ↗Publisher website ·- Open access
Open access under Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC 4.0). Model summary
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elmer Press Inc
- ISSN
- 1920-4531
- Electronic ISSN
- 1920-454X
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about World Journal of Oncology
What CAS zone is World Journal of Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, World Journal of Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at World Journal of Oncology?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 58 days (interquartile range 44–73 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index World Journal of Oncology?
According to LetPub and DOAJ records, World Journal of Oncology is indexed in ESCI and Scopus.
Is World Journal of Oncology open access, and what is the APC?
World Journal of Oncology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .